Shandong Lukang Pharmaceutical Co.,Ltd.’s Net Profit Rose 111.1% in First Three Quarters of 2023

Shandong Lukang Pharmaceutical Co.,Ltd. (山东鲁抗医药股份有限公司) (600789.SH) reported a net profit of 199.9 million yuan in the first three quarters of 2023, up 111.1% year-on-year.

Meanwhile, the company posted 4.7 billion yuan in revenue, up 16.8% year-on-year.

At the end of the reporting period, it had 8.6 billion yuan in total assets and 4.9 billion yuan in total liabilities, with a liability-to-asset ratio of 57.2%.